Please use this identifier to cite or link to this item: http://hdl.handle.net/2080/3847
Title: Investigation of Hemocompatibility and Cytotoxicity of Decellularized Caprine pericardium for Tissue Engineering Applications
Authors: Deepak, Thirumalai
Babu, Anju R
Keywords: Biomaterial
Decellularization
Extracellular matrix
Cytotoxicity
Issue Date: Dec-2022
Citation: International Conference on Biotechnology for Sustainable Bioresources and Bioeconomy (BSBB) IIT Guwahati, India, 7-11 December 2022
Abstract: The pericardium from xenogeneic source is a widely used biomaterial for tissue engineering applications. This study focuses on the hemocompatibility and in-vitro cytotoxicity of the decellularized caprine pericardium. The caprine pericardium was decellularized by sodium dodecyl sulfate (SDS) and Triton X-100. Hemolysis and plasma clotting assay was performed to understand the interaction of decellularized pericardium and whole blood. In-vitro cytotoxicity assay was performed with MG-63 cells to determine the wash-out residues present in the acellular matrix after the decellularization steps. Isolated platelet-poor plasma was incubated with an acellular matrix, and then CaCl2 was added to initiate the plasma recalcification. The treatment with the combination of SDS and Triton X- 100 resulted in an intact decellularized matrix and the absence of cell nuclei was confirmed through histological examination. The hemolysis rate of a decellularized matrix is found to be 2.1% and the matrix met the clinically acceptable implantation limit. The plasma recalcification time of the decellularized matrix is 244 seconds. Incorporating the washing steps in the decellularization process reduces the cytotoxic effect significantly.
Description: Copyright belongs to proceeding publisher
URI: http://hdl.handle.net/2080/3847
Appears in Collections:Conference Papers

Files in This Item:
File Description SizeFormat 
2022_BSBB_TDeepak_Investigation_Poster.pdfPoster1.57 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.